| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/03/1999 | CA2249002A1 Aroc |
| 04/30/1999 | CA2249056A1 Lacc |
| 04/30/1999 | CA2248996A1 Novel ornithine carbamoyltransferase |
| 04/30/1999 | CA2237419A1 An aglucone isoflavone enriched vegetable protein extract and isolate and process for producing |
| 04/30/1999 | CA2219867A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 04/30/1999 | CA2214843A1 A novel inhibitor of platelet activating factor |
| 04/29/1999 | WO1999020787A1 Control of apc-dependent t cell activation by the alpha-1 chain of haptoglobin |
| 04/29/1999 | WO1999020767A1 Modified vitamin k-dependent polypeptides |
| 04/29/1999 | WO1999020764A1 Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 04/29/1999 | WO1999020759A1 Chemokines with amino-terminal modifications |
| 04/29/1999 | WO1999020758A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
| 04/29/1999 | WO1999020757A2 Alpha-7 nicotinic receptor |
| 04/29/1999 | WO1999020756A2 Human toll homologues |
| 04/29/1999 | WO1999020755A2 Novel cytokine receptors |
| 04/29/1999 | WO1999020753A2 Peptide bond formation using nucleic acid catalysts |
| 04/29/1999 | WO1999020751A1 Dna encoding a gababr2 polypeptide and uses thereof |
| 04/29/1999 | WO1999020747A2 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS |
| 04/29/1999 | WO1999020654A2 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT |
| 04/29/1999 | WO1999020653A1 Low-toxicity human interferon-alpha analog |
| 04/29/1999 | WO1999020652A1 Feline granulocyte colony-stimulating factor |
| 04/29/1999 | WO1999020651A1 Novel antifungal compounds |
| 04/29/1999 | WO1999020650A1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS |
| 04/29/1999 | WO1999020645A1 Vesicular amino acid transporter composition and method |
| 04/29/1999 | WO1999020644A1 Secreted proteins and polynucleotides encoding them |
| 04/29/1999 | WO1999020643A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | WO1999020641A1 New triplex forming oligonucleotides and their use in anti-hbv |
| 04/29/1999 | WO1999020311A1 METHODS FOR CANCER IMMUNOTHERAPY USING RETROVIRAL VECTORS EXPRESSING η INTERFERON |
| 04/29/1999 | WO1999020310A1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/29/1999 | WO1999020308A1 A method for inhibiting metastasis and tumor cell growth by clinically modulating tumor expression of fas ligand |
| 04/29/1999 | WO1999020307A1 NOVEL pheS (BETA) |
| 04/29/1999 | WO1999020301A1 Tumour vaccine |
| 04/29/1999 | WO1999020300A1 Inhibition of tumor cell adhesion to type iv collagen |
| 04/29/1999 | WO1999020299A1 Human urinary incontinence and methods of treatment |
| 04/29/1999 | WO1999020298A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | WO1999020297A1 Prevention and treatment of adhesion formation |
| 04/29/1999 | WO1999020296A1 Oral cyclosporin formulations |
| 04/29/1999 | WO1999020295A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | WO1999020293A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/29/1999 | WO1999020288A1 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 04/29/1999 | WO1999020260A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 04/29/1999 | WO1999020253A1 Encapsulation method |
| 04/29/1999 | WO1999020251A1 Use of inhaled no as anti-inflammatory agent |
| 04/29/1999 | WO1999020239A1 Plaque-inhibiting oral compositions |
| 04/29/1999 | WO1999020122A1 Increasing the digestibility of food proteins by thioredoxin reduction |
| 04/29/1999 | WO1999020121A2 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 04/29/1999 | WO1999007740A3 Lipocalin homologs |
| 04/29/1999 | WO1999007401A3 The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 04/29/1999 | WO1999006551A3 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES |
| 04/29/1999 | WO1999006066A3 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 04/29/1999 | WO1999006026A9 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 04/29/1999 | WO1999005165A8 Streptogramines, their preparation and compositions containing them |
| 04/29/1999 | WO1999004825A9 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders |
| 04/29/1999 | WO1999004775A9 Method of treating dopaminergic and gaba-nergic disorders |
| 04/29/1999 | WO1999003452A9 Methods of removing residual solvent from nasal drug delivery compositions |
| 04/29/1999 | WO1998058669A3 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 04/29/1999 | WO1998048027A9 Materials and methods for treatment of retinal diseases |
| 04/29/1999 | WO1998042296A9 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 04/29/1999 | DE19821843A1 Preparation of autologous human blood cytokine(s) |
| 04/29/1999 | DE19756864C1 Production of neuronal or glial progenitor cells |
| 04/29/1999 | DE19746868A1 Use of tumour necrosis factor antagonists |
| 04/29/1999 | CA2308114A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
| 04/29/1999 | CA2308013A1 Human checkpoint kinase, hcds1, compositions and methods |
| 04/29/1999 | CA2307639A1 Tumour vaccine |
| 04/29/1999 | CA2307322A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 04/29/1999 | CA2306983A1 Methods for treating hypercoagulable states or acquired protein c deficiency |
| 04/29/1999 | CA2306953A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | CA2306731A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | CA2306629A1 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 04/29/1999 | CA2306457A1 Secreted proteins and polynucleotides encoding them |
| 04/29/1999 | CA2306251A1 Alpha-7 nicotinic receptor |
| 04/29/1999 | CA2306204A1 J-chain and analogues as epithelial cell targeting conjugates |
| 04/29/1999 | CA2305804A1 Plaque-inhibiting oral compositions |
| 04/29/1999 | CA2305385A1 Human toll homologues |
| 04/29/1999 | CA2275773A1 Oral cyclosporin formulations |
| 04/29/1999 | CA2273193A1 Novel human .beta.2 integrin alpha subunit |
| 04/28/1999 | EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5 |
| 04/28/1999 | EP0911413A2 Minimal adenovirus-based gene therapy vector |
| 04/28/1999 | EP0911410A2 Era polynucleotides and polypeptides from Streptococcus pneumoniae belonging to the GTPase family |
| 04/28/1999 | EP0911409A2 Deformylase |
| 04/28/1999 | EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911405A2 Gapdh |
| 04/28/1999 | EP0911403A2 MurB gene from Streptococcus pneumoniae |
| 04/28/1999 | EP0911402A2 PyrR homolog from Staphylococcus aureus |
| 04/28/1999 | EP0911400A1 Antisense compounds to cd14 |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911398A2 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 04/28/1999 | EP0911397A1 Tumor antigen proteins, genes thereof, and tumor antigen peptides |
| 04/28/1999 | EP0911393A1 Novel peptide, process for the production of the same, and use of the same |
| 04/28/1999 | EP0911391A2 A clone HWHHJ20 |
| 04/28/1999 | EP0911390A2 Protein kinases as tools for the diagnosis and treatment of Alzheimer's disease |
| 04/28/1999 | EP0911342A1 Novel protein and process for producing the same |
| 04/28/1999 | EP0911341A1 Adenine nucleotide translocator |
| 04/28/1999 | EP0911340A2 Substituted Isoquinolin-3-Carboxyamides, their preparation and medical use |
| 04/28/1999 | EP0911035A2 Insoluble insulin compositions |
| 04/28/1999 | EP0911034A1 Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy |
| 04/28/1999 | EP0911033A2 Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 04/28/1999 | EP0910659A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 04/28/1999 | EP0910654A1 Enzyme combinations for destroying proliferative cells |
| 04/28/1999 | EP0910648A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods |